Adapti Posts $2.9M Q3 Loss as Revenue Jumps but Operating Costs Surge
Adapti reported a net loss of $2.9 million for the quarter ended December 31, 2025, compared to a $285,071 loss in the prior-year period. Revenue climbed to $1.5 million from just $1,244 a year earlier.
Adapti reported a net loss of $2.9 million for the quarter ended December 31, 2025, widening from a $285,071 loss in the same quarter of 2024. Revenue for the three-month period reached $1.5 million, up sharply from $1,244 in the prior-year quarter. Read more earnings reports.
For the nine months ended December 31, 2025, the company posted a net loss of $5.8 million compared to a $715,946 loss for the nine months ended December 31, 2024. Revenue for the nine-month period totaled $3.7 million, up from $4,222 in the comparable prior-year period.
Operating expenses jumped to $2.8 million in the most recent quarter from $268,763 a year earlier. For the nine-month period, operating expenses climbed to $6.3 million from $682,166.
Gross profit for the December quarter came in at $60,753 on cost of revenue of $1.5 million. For the nine months ended December 31, 2025, gross profit was $859,329 with cost of revenue at $2.8 million.
The company swung to positive stockholders' equity of $13.5 million as of December 31, 2025, from negative equity of $1.04 million as of March 31, 2025. Total assets surged to $31.8 million from just $1,212 at the end of the prior fiscal year.
Adapti raised $1.6 million from financing activities during the nine-month period compared to $250,000 in the prior-year period. Cash used in operations was $1.4 million for the nine months ended December 31, 2025, compared to $225,040 in the same period of 2024.
Total liabilities stood at $18.3 million as of December 31, 2025, up from $1.04 million as of March 31, 2025. Current liabilities increased to $5.7 million from $1.03 million over the same period.
Accounts receivable rose to $245,890 as of December 31, 2025, from $640 at the end of March 2025. The company reported intangible assets of $6.0 million on its balance sheet as of December 31, 2025.
Basic and diluted loss per share for the quarter ended December 31, 2025, was $0.37 compared to $0.19 in the prior-year quarter. For the nine-month period, loss per share was $0.93 compared to $0.48 a year earlier.
Common shares outstanding increased to 8.1 million as of December 31, 2025, from 1.5 million as of March 31, 2025.
| Financial Metric | Q3 FY2026 (Dec 31, 2025) | Q3 FY2025 (Dec 31, 2024) |
|---|---|---|
| Total Revenue | $1,525,695 | $1,244 |
| Gross Profit | $60,753 | $1,244 |
| Operating Loss | ($2,726,557) | ($267,519) |
| Net Loss | ($2,946,326) | ($285,071) |
| Loss Per Share (Basic) | ($0.37) | ($0.19) |
| Financial Metric | 9 Months FY2026 | 9 Months FY2025 |
|---|---|---|
| Total Revenue | $3,657,796 | $4,222 |
| Gross Profit | $859,329 | $4,222 |
| Operating Loss | ($5,417,768) | ($677,944) |
| Net Loss | ($5,837,708) | ($715,946) |
| Cash from Operations | ($1,369,718) | ($225,040) |
| Balance Sheet Item | Dec 31, 2025 | Mar 31, 2025 |
|---|---|---|
| Total Assets | $31,790,593 | $1,212 |
| Total Liabilities | $18,291,939 | $1,038,987 |
| Stockholders' Equity | $13,498,654 | ($1,037,775) |
| Shares Outstanding | 8,098,729 | 1,532,388 |